510(k) device
Encora X1
Encora, Inc. · External Upper Limb Tremor Stimulator (QBC, Class II) · First FDA decision Feb 5, 2026, newest Feb 5, 2026Essential tremor
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
1
Naming "Encora X1"
MAUDE reports
0
Brand "Encora X1", since 2015
PubMed studies
0
Mentioning "Encora X1"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Encora X1
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Encora X1510(k)
K251517 · Decided Feb 5, 2026 · 265 days after receipt
Device type: External Upper Limb Tremor Stimulator (QBC) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- External Upper Limb Tremor Stimulator TherapyLocal determinationIn effectL39591CGS Administrators, LLCUpdated Feb 16, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Encora X1", any status and sponsor, newest update first.
Encora, Inc.Not on our public-company list
NCT07911488 · 1,000 participants (planned) · Start Nov 1, 2026 · Primary completion Nov 2031
Device: Encora X1 · For: Essential Tremor
Sites: Boston, Massachusetts
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Encora X1", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QBC
6 reports: 0 malfunction, 6 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Encora X1"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QBC.
- Cala kIQCala Health, Inc. · 510(k) 2025
- Cala kIQ PlusCala Health, Inc. · 510(k) 2026
- Felix NeuroAI SystemFasikl Incorporated · 510(k) 2025
- Cala TrioCala Health, Inc. · 510(k) 2021
- External upper limb tremor stimulatorCala Health, Inc. · 510(k) 2018
- Cala ONECala Health, Inc. · De Novo 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.